The Toxoplasma gondii F-Box Protein L2 Functions as a Repressor of Stage Specific Gene Expression
Carlos G. Baptista,Sarah Hosking,Elisabet Gas-Pascual,Loic Ciampossine,Steven Abel,Mohamed-Ali Hakimi,Victoria Jeffers,Karine Le Roch,Christopher M. West,Ira J. Blader
DOI: https://doi.org/10.1371/journal.ppat.1012269
IF: 7.464
2024-05-31
PLoS Pathogens
Abstract:Toxoplasma gondii is a foodborne pathogen that can cause severe and life-threatening infections in fetuses and immunocompromised patients. Felids are its only definitive hosts, and a wide range of animals, including humans, serve as intermediate hosts. When the transmissible bradyzoite stage is orally ingested by felids, they transform into merozoites that expand asexually, ultimately generating millions of gametes for the parasite sexual cycle. However, bradyzoites in intermediate hosts differentiate exclusively to disease-causing tachyzoites, which rapidly disseminate throughout the host. Though tachyzoites are well-studied, the molecular mechanisms governing transitioning between developmental stages are poorly understood. Each parasite stage can be distinguished by a characteristic transcriptional signature, with one signature being repressed during the other stages. Switching between stages require substantial changes in the proteome, which is achieved in part by ubiquitination. F-box proteins mediate protein poly-ubiquitination by recruiting substrates to SKP1, Cullin-1, F-Box protein E3 ubiquitin ligase (SCF-E3) complexes. We have identified an F-box protein named Toxoplasma gondii F-Box Protein L2 (TgFBXL2), which localizes to distinct perinucleolar sites. TgFBXL2 is stably engaged in an SCF-E3 complex that is surprisingly also associated with a COP9 signalosome complex that negatively regulates SCF-E3 function. At the cellular level, TgFBXL2-depleted parasites are severely defective in centrosome replication and daughter cell development. Most remarkable, RNAseq data show that TgFBXL2 conditional depletion induces the expression of stage-specific genes including a a large cohort of genes necessary for sexual commitment. Together, these data suggest that TgFBXL2 is a latent guardian of stage specific gene expression in Toxoplasma and poised to remove conflicting proteins in response to an unknown trigger of development. Toxoplasma gondii exists as three major forms—disease-causing tachyzoites, transmissible bradyzoites, and sexual stages that develop in felid intestines. Each stage is typified by stage specific genes that are silenced in other stages and proper silencing is important for parasite growth. Previously, we identified in Toxoplasma a family of proteins, called F-box proteins, that are the substrate recruiting subunits of the SCF-E3 ubiquitin ligase complex. Of these, TgFBLX2 is predicted to be the most important for tachyzoite growth. Here, epitope-tagged TgFBLX2 was found to localize to a perinucleolar compartment in tachyzoites without apparently interacting with chromatin. A TgFBLX2 conditional expression strain revealed that TgFBLX2 is an essential tachyzoite gene whose loss leads to centrosome replication and daughter cell development defects. Next, we used RNAseq analysis to identify TgFBLX2-regulated genes and found that its loss led to the aberrant expression of non-tachyzoite stage specific genes including many sexual stage genes. Interestingly, TgFBLX2 interactome analyses revealed that the TgFBLX2-containing SCF-E3 is associated with the COP9 signalsome, which is a negative regulator of the SCF-E3 but does not interact with other known regulators of stage specific gene expression. Together, these data reveal TgFBLX2 as a novel negative regulator of stage specific gene expression.
microbiology,virology,parasitology